135 related articles for article (PubMed ID: 31250756)
1. The Role of Shcbp1 in Signaling and Disease.
Zhang GY; Ma ZJ; Wang L; Sun RF; Jiang XY; Yang XJ; Long B; Ye HL; Zhang SZ; Yu ZY; Shi WG; Jiao ZY
Curr Cancer Drug Targets; 2019; 19(11):854-862. PubMed ID: 31250756
[TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
5. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract][Full Text] [Related]
6. Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells.
Tao HC; Wang HX; Dai M; Gu CY; Wang Q; Han ZG; Cai B
Asian Pac J Cancer Prev; 2013; 14(10):5645-50. PubMed ID: 24289556
[TBL] [Abstract][Full Text] [Related]
7. SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.
Feng W; Li HC; Xu K; Chen YF; Pan LY; Mei Y; Cai H; Jiang YM; Chen T; Feng DX
Gene; 2016 Aug; 587(1):91-7. PubMed ID: 27129942
[TBL] [Abstract][Full Text] [Related]
8. Biological functions and therapeutic potential of SHCBP1 in human cancer.
Lin Y; Cai H
Biomed Pharmacother; 2023 Apr; 160():114362. PubMed ID: 36739763
[TBL] [Abstract][Full Text] [Related]
9. SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway.
Ren C; Zhou Z; Wang X; Hua X; Zou M; Zhang X
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):136-143. PubMed ID: 32769441
[TBL] [Abstract][Full Text] [Related]
10. Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.
Dai Y; Hu C; Zhou H; Liu W; Lai W; Xu R; Liao J; Wang J; Li G; Zhang R
FEBS J; 2023 Dec; 290(24):5720-5743. PubMed ID: 37581853
[TBL] [Abstract][Full Text] [Related]
11. Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
Sun Y; Pan H; He Y; Hu C; Gu Y
Head Neck; 2022 Mar; 44(3):591-605. PubMed ID: 34918847
[TBL] [Abstract][Full Text] [Related]
12. SHCBP1 is required for midbody organization and cytokinesis completion.
Asano E; Hasegawa H; Hyodo T; Ito S; Maeda M; Chen D; Takahashi M; Hamaguchi M; Senga T
Cell Cycle; 2014; 13(17):2744-51. PubMed ID: 25486361
[TBL] [Abstract][Full Text] [Related]
13. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Yin H; Zhang C; Wei Z; He W; Xu N; Xu Y; Li T; Ren K; Kuang Y; Zhu X; Yuan F; Yu H; Gou X
Cell Death Dis; 2022 Jan; 13(1):39. PubMed ID: 35013128
[TBL] [Abstract][Full Text] [Related]
14. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
15. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
Liu L; Yang Y; Liu S; Tao T; Cai J; Wu J; Guan H; Zhu X; He Z; Li J; Song E; Zeng M; Li M
Oncogene; 2019 Jan; 38(5):747-764. PubMed ID: 30177836
[TBL] [Abstract][Full Text] [Related]
16. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
17. The Aurora-B-mediated phosphorylation of SHCBP1 regulates cytokinetic furrow ingression.
Asano E; Hasegawa H; Hyodo T; Ito S; Maeda M; Takahashi M; Hamaguchi M; Senga T
J Cell Sci; 2013 Aug; 126(Pt 15):3263-70. PubMed ID: 23704356
[TBL] [Abstract][Full Text] [Related]
18. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.
Shi W; Zhang G; Ma Z; Li L; Liu M; Qin L; Yu Z; Zhao L; Liu Y; Zhang X; Qin J; Ye H; Jiang X; Zhou H; Sun H; Jiao Z
Nat Commun; 2021 May; 12(1):2812. PubMed ID: 33990570
[TBL] [Abstract][Full Text] [Related]
19. Unexpected phenotype of mice lacking Shcbp1, a protein induced during T cell proliferation.
Buckley MW; Arandjelovic S; Trampont PC; Kim TS; Braciale TJ; Ravichandran KS
PLoS One; 2014; 9(8):e105576. PubMed ID: 25153088
[TBL] [Abstract][Full Text] [Related]
20. FGF13 interaction with SHCBP1 activates AKT-GSK3α/β signaling and promotes the proliferation of A549 cells.
Lu H; Yin M; Wang L; Cheng J; Cheng W; An H; Zhang T
Cancer Biol Ther; 2020 Nov; 21(11):1014-1024. PubMed ID: 33064958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]